Lithium treatment is one of the major causes of the acquired form of nephrogenic diabetes insipidus (NDI), a clinical syndrome in which the kidney is unable to concentrate urine despite normal or elevated concentrations of the antidiuretic hormone arginine vasopressin. The gene discussed is AVP; the disease is nephrogenic diabetes insipidus.